Stockscreener 앱 받기
1.00%
Davita Inc 주식(DVA)의 최신 뉴스
Warren Buffett Sold These 12 Stocks Over the Past 6 Months: Should You Sell Them Too? - The Motley Fool
DaVita HealthCare (DVA) Rises As Market Takes a Dip: Key Facts - Yahoo Finance
DaVita Stock Declines 1.2% in 3 Months: Here's How to Play - Yahoo Finance
DaVita HealthCare (DVA) Exceeds Market Returns: Some Facts to Consider - Yahoo Finance
DaVita Inc. (DVA) Stock Forecasts - Yahoo Finance
DaVita's Dialysis Business Is Surrounded by a Narrow Moat - Morningstar
Allen learns about dialysis legislation - Statesboro Herald
Why DaVita Inc. (NYSE:DVA) Looks Like A Quality Company - Yahoo Finance
DaVita HealthCare (DVA) Increases Yet Falls Behind Market: What Investors Need to Know - Yahoo Finance
DaVita Inc (DVA) Stock Price Up 0.67% on Mar 19 - GuruFocus.com
The DaVita Dilemma: Flat Patient Enrollment And Lawsuits, Yet An Improvement In Net Income Margin - Seeking Alpha
DaVita (DVA) Shares Decline as Berkshire Hathaway Reduces Stake - GuruFocus.com
Is DaVita Inc. (DVA) the Best Healthcare Stock For Long-Term Investment? - Insider Monkey
US Bancorp DE Sells 1,098 Shares of DaVita Inc. (NYSE:DVA) - Defense World
DaVita HealthCare (DVA) Suffers a Larger Drop Than the General Market: Key Insights - Yahoo Finance
Charles Schwab Investment Management Inc. Has $73.17 Million Stock Position in DaVita Inc. (NYSE:DVA) - Defense World
SBI Securities Co. Ltd. Invests $41,000 in DaVita Inc. (NYSE:DVA) - Defense World
Flexibility of a Home Dialysis Nurse - CSRwire.com
DaVita at Barclays Healthcare Conference: Strategic Insights Amid Challenges - Investing.com
3 Reasons to Sell DVA and 1 Stock to Buy Instead - The Globe and Mail
Mutual of America Capital Management LLC Sells 281 Shares of DaVita Inc. (NYSE:DVA) - Defense World
Flexibility Of A Home Dialysis Nurse - MENAFN.COM
CADE challenges DaVita’s acquisition of Brasnefro — Conselho Administrativo de Defesa Econômica - GOV.BR
Is Now An Opportune Moment To Examine DaVita Inc. (NYSE:DVA)? - Simply Wall St
DaVita Inc (DVA) to Participate in Barclays Global Healthcare Conference 2025 - GuruFocus.com
DaVita: A Buffett-Backed Healthcare Stock Worth Watching - Forbes
DaVita Inc. to Participate in the Barclays Global Healthcare Conference 2025 - PR Newswire
Sanctuary Advisors LLC Acquires New Position in DaVita Inc. (NYSE:DVA) - Defense World
Day in the Life: Cristina, DaVita PD Registered Nurse - CSRwire.com
Bank of New York Mellon Corp Decreases Stock Holdings in DaVita Inc. (NYSE:DVA) - Defense World
Day In The Life: Cristina, Davita PD Registered Nurse - MENAFN.COM
With EPS Growth And More, DaVita (NYSE:DVA) Makes An Interesting Case - Yahoo Finance UK
Day in the Life: Ansel, DaVita Home Hemodialysis Registered Nurse - CSRwire.com
Principal Financial Group Inc. Has $8.68 Million Stock Position in DaVita Inc. (NYSE:DVA) - Defense World
Fjarde AP Fonden Fourth Swedish National Pension Fund Has $1.49 Million Stock Position in DaVita Inc. (NYSE:DVA) - MarketBeat
Ieq Capital LLC Lowers Holdings in DaVita Inc. (NYSE:DVA) - MarketBeat
Handelsbanken Fonder AB Lowers Holdings in DaVita Inc. (NYSE:DVA) - MarketBeat
DaVitaMeet the Mentor - CBS News
New York State Common Retirement Fund Sells 2,500 Shares of DaVita Inc. (NYSE:DVA) - MarketBeat
Blue Trust Inc. Has $34,000 Stock Holdings in DaVita Inc. (NYSE:DVA) - Defense World
Day In The Life: Ansel, Davita Home Hemodialysis Registered Nurse - MENAFN.COM
YMCA of the USA Deepens Collaboration with DaVita to Drive Kidney Health Initiatives in Seven Communities - GlobeNewswire
DaVita Inc. to Host Earnings Call - ACCESS Newswire
Investor Network: DaVita Inc. to Host Earnings Call - ACCESS Newswire
Bryn Mawr Capital Management LLC Reduces Holdings in DaVita Inc. (NYSE:DVA) - MarketBeat
DaVita's SWOT analysis: kidney care giant's stock navigates policy shifts - Investing.com India
DaVita's SWOT analysis: kidney care giant's stock navigates policy shifts By Investing.com - Investing.com UK
Rhumbline Advisers Lowers Position in DaVita Inc. (NYSE:DVA) - MarketBeat
DaVita Inc.: Is Their Expectation Regarding Revenue Per Treatment Growth Reasonable? - Smartkarma
1.37%
1.54%
자본화:
|
볼륨(24시간):